T32HL176457
Project Grant
Overview
Grant Description
Cardiovascular Science Training Program (CSTP) - The Cardiovascular Science Training Program (CSTP) at the Icahn School of Medicine at Mount Sinai School (ISMMS) is dedicated to recruiting and training a cohort of pre-doctoral and post-doctoral scientists, aiming to foster their independent careers in cardiovascular research.
Given the persistent health challenges associated with cardiovascular disease, understanding the cellular and molecular foundations of cardiac pathologies is crucial for discovering effective treatment strategies.
The Icahn School of Medicine is ranked No. 10 in the nation for NIH funding by the Blue Ridge Institute for Medical Research, as well as number 1 in New York and No. 4 globally on Newsweek’s list of “The World’s Best Specialized Hospitals.”
Drs. Filip Swirski and Carol Gregorio, the program directors, are internationally-recognized scientists with outstanding credentials in leadership, research and mentorship.
The training program offers its trainees vast opportunities in different areas relevant to cardiovascular science, including but not limited to vascular biology, cardioimmunology, electrophysiology, myocardial disease, genetics, development, metabolic diseases, stem cell/gene therapeutics, artificial intelligence, systems biology, and drug discovery, with cross-cutting opportunities in disciplines that highlight programs at Mount Sinai that are well-developed and internationally-recognized including advanced imaging and genomics/personalized medicine.
The Cardiovascular Research Institute (CVRI), under the leadership of Dr. Swirski, along with various translational research institutes on the ISMMS campus, provides trainees with access to cutting-edge research facilities.
The CSTP offers training positions to graduate students, Ph.D. post-doctoral fellows, and physician-scientist fellows, each with specific selection processes tailored to their respective educational backgrounds.
The program offers intensive fellowships in one of 27 laboratories, didactic training, professional development, as well as rigorous training in the responsible conduct of research and in methods for enhancing reproducibility.
Trainees participate in weekly research seminars and have access to courses through the Mount Sinai Graduate School of Biomedical Sciences.
Annual evaluations, based on well-defined criteria for professional advancement, assess trainee progress.
Opportunities for interaction with established investigators and past trainees, who have successfully advanced through the CSTP, are provided.
Each trainee, in collaboration with their primary mentor, develops an individual development plan evaluated by the program directors.
Internal and external advisory committees evaluate the program based on benchmarks such as trainee progress, recruitment success, extramural funding, and the career paths of former trainees.
Our primary objective is to cultivate the next generation of fundamental and translational investigators, including clinician/scientists, within an environment that nurtures their professional growth and independence.
Given the persistent health challenges associated with cardiovascular disease, understanding the cellular and molecular foundations of cardiac pathologies is crucial for discovering effective treatment strategies.
The Icahn School of Medicine is ranked No. 10 in the nation for NIH funding by the Blue Ridge Institute for Medical Research, as well as number 1 in New York and No. 4 globally on Newsweek’s list of “The World’s Best Specialized Hospitals.”
Drs. Filip Swirski and Carol Gregorio, the program directors, are internationally-recognized scientists with outstanding credentials in leadership, research and mentorship.
The training program offers its trainees vast opportunities in different areas relevant to cardiovascular science, including but not limited to vascular biology, cardioimmunology, electrophysiology, myocardial disease, genetics, development, metabolic diseases, stem cell/gene therapeutics, artificial intelligence, systems biology, and drug discovery, with cross-cutting opportunities in disciplines that highlight programs at Mount Sinai that are well-developed and internationally-recognized including advanced imaging and genomics/personalized medicine.
The Cardiovascular Research Institute (CVRI), under the leadership of Dr. Swirski, along with various translational research institutes on the ISMMS campus, provides trainees with access to cutting-edge research facilities.
The CSTP offers training positions to graduate students, Ph.D. post-doctoral fellows, and physician-scientist fellows, each with specific selection processes tailored to their respective educational backgrounds.
The program offers intensive fellowships in one of 27 laboratories, didactic training, professional development, as well as rigorous training in the responsible conduct of research and in methods for enhancing reproducibility.
Trainees participate in weekly research seminars and have access to courses through the Mount Sinai Graduate School of Biomedical Sciences.
Annual evaluations, based on well-defined criteria for professional advancement, assess trainee progress.
Opportunities for interaction with established investigators and past trainees, who have successfully advanced through the CSTP, are provided.
Each trainee, in collaboration with their primary mentor, develops an individual development plan evaluated by the program directors.
Internal and external advisory committees evaluate the program based on benchmarks such as trainee progress, recruitment success, extramural funding, and the career paths of former trainees.
Our primary objective is to cultivate the next generation of fundamental and translational investigators, including clinician/scientists, within an environment that nurtures their professional growth and independence.
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100296504
United States
Geographic Scope
Single Zip Code
Icahn School Of Medicine At Mount Sinai was awarded
Project Grant T32HL176457
worth $447,977
from National Heart Lung and Blood Institute in September 2025 with work to be completed primarily in New York New York United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.837 Cardiovascular Diseases Research.
The Project Grant was awarded through grant opportunity Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
9/1/25
Start Date
8/31/30
End Date
Funding Split
$448.0K
Federal Obligation
$0.0
Non-Federal Obligation
$448.0K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
T32HL176457
SAI Number
T32HL176457-2120845053
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
C8H9CNG1VBD9
Awardee CAGE
1QSQ9
Performance District
NY-13
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 8/20/25